Patent application number | Description | Published |
20110311462 | COMPOSITIONS FOR TREATMENT OF EAR DISORDERS AND METHODS OF USE THEREOF - The present invention relates to compositions and methods useful for the treatment of ear disorders, administered to a treated ear in the form of a foam or a mousse. Administering a medicament in such forms will increase the residence time of the medicament in the ear canal, provide relatively uniform distribution of the composition, and can increase the penetration of the active pharmaceutical ingredient in the affected area, may release active substances slowly, enhance treatment effectiveness, increase compliance and is more convenient to use than currently available ear medications. The administration in the form of a foam or a mousse may preferably be provided as a metered dose, of a volume suitable to fill the ear canal. | 12-22-2011 |
20120000931 | MULTIPLE-METERED SELF-CLEANING DISPENSER - A method for dispensing a plurality of metered doses of a fluid, comprising: providing a fluid in a container comprising a plurality of metering chambers and a plurality of tubes connectable to and movable relative to the chambers, wherein the tubes are externally open or open to the fluid; connecting to the chambers tubes open to the fluid, thereby loading the chambers with fluid; and selectively connecting one or more externally open tubes to one or more chambers, thereby dispensing the fluid contents of the one or more chambers via an external opening. | 01-05-2012 |
20120059337 | CATHETER WITH ASYMMETRIC OR COLLAPSIBLE-EXPANDABLE CROSS-SECTION - A catheter including a continuous envelope forming an open-bore shaft. The envelope is characterized by a main longitudinal axis and a sagittal cross section. At least a portion of the sagittal cross section may be characterized by at least one asymmetric property that extends along the main longitudinal axis in a predetermined pattern. | 03-08-2012 |
20120082627 | OTIC FOAM FORMULATIONS - The present invention relates to foamable otic pharmaceutical compositions comprising fluoroquinolones and methods of preparing same. Particularly, the present invention relates to pharmaceutical compositions comprising oil-in-water emulsions comprising fluoroquinolones and gas propellants, administered to the ear as foam for treating ear disorders. | 04-05-2012 |
20120179122 | DEVICE FOR APPLYING AN OPHTHALMIC MEDICAMENT MIST - A device for applying an ophthalmologic medicament to a patient's eye is disclosed. The device comprises spectacles defined by a frame and at least one lens; at least one container adapted for accommodating the ophthalmologic medicament; the container is incorporated into the frame; dosing mechanism adapted to control doses of the medicament; and at least one nozzle in a fluid interconnection with the medicament container; the nozzle is secured mechanically to the frame; the nozzle is adapted for providing a medicament mist flow. The nozzle is placed in front of a peripheral portion of a patient's eye slot and adapted to provide the mist flow in front of the patient's eye. | 07-12-2012 |
20120252720 | COMPOSITIONS FOR TREATMENT OF EAR DISORDERS AND METHODS OF USE THEREOF - The present invention relates to compositions and methods useful for the treatment of ear disorders, administered to a treated ear in the form of a foam or a mousse. Administering a medicament in such forms will increase the residence time of the medicament in the ear canal, provide relatively uniform distribution of the composition, and can increase the penetration of the active pharmaceutical ingredient in the affected area, may release active substances slowly, enhance treatment effectiveness, increase compliance and is more convenient to use than currently available ear medications. The administration in the form of a foam or a mousse may preferably be provided as a metered dose, of a volume suitable to fill the ear canal. | 10-04-2012 |
20140234227 | FOAM FORMULATIONS - The present invention provides foamable pharmaceutical compositions comprising water-soluble antibiotics and anti-inflammatory steroids and methods of preparing same. Particularly, the present invention relates to oil-free pharmaceutical compositions comprising a quinolone, an anti-inflammatory steroid, a polar co-solvent, and propellant gas, administered to the ear in the form of foam for treating ear disorders. | 08-21-2014 |
20140255521 | TOPICAL COMPOSITIONS AND METHODS OF TREATMENT OF TOPICAL DISORDERS - A topical composition includes at least one film forming ingredient; at least one surfactant; at least one non-polar volatile siloxane solvent; at least 15% (w/w) water; and a therapeutically effective concentration of at least one pharmaceutical agent, wherein the composition is sufficiently designed to dry within 60 seconds after application to a body surface to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time. | 09-11-2014 |
20140255522 | TOPICAL COMPOSITIONS AND METHODS OF TREATMENT OF ANORECTAL AND GENITAL DISORDERS - A topical anorectal or genital composition includes at least one film forming ingredient; at least one surfactant; at least one non-polar volatile siloxane solvent; at least 15% (w/w) water, and a therapeutically effective concentration of at least one pharmaceutical agent, wherein the composition is sufficiently designed to dry within 60 seconds after application to the anorectal or genital surface to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time. | 09-11-2014 |
20140256688 | TOPICAL COMPOSITIONS AND METHODS OF TREATMENT OF ANORECTAL DISORDERS - A topical anorectal composition includes trimethylsiloxysilicate; at least one surfactant selected from the group consisting of sodium lauryl sulfate, alkyl- and alkoxy-dimethicone copolyol, polysorbate and a combination thereof; a non-polar volatile siloxane solvent; at least 15% (w/w) water; and a pharmaceutical agent selected from the group consisting of pramoxine, phenylephrine, hydrocortisone, salicylic acid, nitroglycerine, sildenafil, or their salts and combinations thereof, wherein the composition is sufficiently designed to dry within 60 seconds after application to the anorectal mucosa to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time. | 09-11-2014 |
20140326056 | Method for Quick Assessment of Osmolarity - An osmolarity measuring device for providing a semi-quantitative color measure of liquid's osmolarity, said device comprising: a. none or more coloring agents; b. none or more swelling agents; c. none or more solutions; d. a vesicle with a continuous integument, containing within said integument at least one of a group consisting of said coloring agent, said swelling agent and said solution; and e. a support of absorbent material impregnated in at least one area with a plurality of said vesicles; wherein the apparent color of said area alters if the osmolarity of said liquid is within a pre-determined range. | 11-06-2014 |
20140357971 | DRY EYE DIAGNOSTIC - The present invention discloses a tear analyzing strip (TAS) for measuring dry eye syndrome in a patient. The TAS comprises an elongated body comprising a proximal portion and a distal portion interconnected by a main longitudinal axis. The distal portion comprises at least one tear channel comprising at least one tear receiving portion in fluid communication with an eye of the patient such that tears sampled from the eye into the channel. Reagent pads disposed along the length of the distal portion. The reagent pad is in fluid communication with the tear channel such that tears flow through the tear channel towards the reagent pads, thereby progressively wetting the reagent pads. Each of the reagent pads comprises an effective measure of a reagent capable of biological, physical, or chemical activation by the tears or a component thereof and of providing a visible indication of the activation. | 12-04-2014 |